No. 36, Jingha 2nd Road
Beijing Economic and Technological Development Zone
Beijing 100176
China
86 10 6751 9888
https://www.staidson.com
Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter: 555
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Mr. Wang Chao | General Manager | N/A | N/A | 1982 |
Mr. Shicheng Li | Financial Director | N/A | N/A | 1982 |
Mr. Jiguang Zhao | Deputy General Manager | N/A | N/A | 1975 |
Mr. Maorong Yu | Secretary of the Board & Deputy GM | N/A | N/A | 1981 |
Staidson (Beijing) BioPharmaceuticals Co., Ltd. primarily engages in the research and development, production, and marketing of therapeutic drugs in China. The company offers protein drugs, including therapeutic monoclonal antibody drugs; gene therapy/cell therapy drugs; and chemical drugs. It principally offers its products under the fields of nervous system related, infectious, gastrointestinal, urinary system, and autoimmune diseases. Staidson (Beijing) BioPharmaceuticals Co., Ltd. was founded in 2002 and is based in Beijing, China.
Staidson (Beijing) BioPharmaceuticals Co., Ltd.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.